Development and Effectiveness of Cognitive Behavioral Therapy Based Weight Control Mobile Application "BI'KILO"
Bilişsel Davranışçı Terapi Temelli Kilo Kontrolü Mobil "Bİ'KİLO" Uygulamasının Geliştirilmesi ve Etkililiğinin Sınanması
1 other identifier
interventional
70
1 country
1
Brief Summary
The primary purpose of this project is to observe the effects of Cognitive Behavioral Psychotherapy-based weight-loss mobile application (Bi' Kilo) in 4 essential areas (Anthropometric, Biochemical, Psychometric, Cognitive) in overweight and obese individuals and to test whether these effects will persist after ten weeks. In this context, the original value of the proposed study is that a mobile application will be produced that is suitable for the culture and whose effectiveness has been scientifically proven. In our current project proposal, the measurements of the participants will be evaluated holistically together with both tests and inventories, as well as physical measurements and biochemical data. In this study, the usability of the mobile application to be developed will also be evaluated and reported. The study group of the research will consist of overweight and obese individuals. The first stage will be a pilot study to identify the shortcomings of the Bi'Kilo mobile application. After eliminating the deficiencies of the Bi' Kilo mobile application, a working group will be formed in the second phase of the research. At this stage, the sample will be divided into two different groups within the scope of the study and a study group and a control group will be formed. The study consists of three phases as preparation, implementation, and follow-up. Measurements of the participants will be made at the beginning (Anthropometric, Biochemical, Psychometric, Cognitive), at the end of the six-week implementation phase (Anthropometric), and at the end of the four-week follow-up phase (Anthropometric, Biochemical, Psychometric, Cognitive).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 15, 2022
CompletedFirst Submitted
Initial submission to the registry
March 6, 2024
CompletedFirst Posted
Study publicly available on registry
April 11, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 15, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 15, 2024
CompletedApril 16, 2025
April 1, 2024
2 years
March 6, 2024
April 13, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Body Mass Index (BMI)
Body Mass Index is a person's weight in kilograms divided by the square of height in meters.
Pre-test, post-test (6 weeks later from pre-test), follow up (10 weeks later from pre-test)
Secondary Outcomes (20)
Weight
Pre-test, post-test (6 weeks later from pre-test), follow up (10 weeks later from pre-test)
Height
Pre-test
Waist Circumference (WC)
Pre-test, post-test (6 weeks later from pre-test), follow up (10 weeks later from pre-test)
Hip Circumference
Pre-test, post-test (6 weeks later from pre-test), follow up (10 weeks later from pre-test)
Waist-Hip Ratio (WHR)
Pre-test, post-test (6 weeks later from pre-test), follow up (10 weeks later from pre-test)
- +15 more secondary outcomes
Other Outcomes (5)
Demographic Information Form
Pre-test
Structured Clinical Interview for DSM-5 Disorders (SCID-5)
Pre-test
The Eating Disorder Assessment for DSM-5 (EDA-5)
Pre-test
- +2 more other outcomes
Study Arms (2)
Treatment Group
EXPERIMENTALParticipants in the treatment group will be involved in a process that includes three phases of the study: preparation phase, implementation phase and follow-up phase.
Control Group
NO INTERVENTIONThe control group will not be able to access the entire treatment program content. However, they will be able to access animation contents such as energy balance training, eating change, planning where and when and what to eat, healthy weight loss targets, three main and three snacks, determining weight loss targets and informational content titled diet types specified in the nutrition education module for a period of 6 weeks.
Interventions
The study consists of three stages: preparation phase, implementation phase and follow-up phase. During the preparation phase, participants' weight and body fat ratio will be calculated using a body analysis scale, and their height, waist and hip circumference will be measured. The implementation phase will last six weeks and consists of six modules, each lasting one week. The skills and practices aimed to be acquired in each module will be required to be applied in the following practice modules. At the end of the implementation phase, participants' weight, waist and hip circumferences will be measured again. The final phase, called the follow-up phase, will last four weeks. During this phase, participants will continue to keep a self-monitoring record of their eating and physical exercise, complete a hunger scale, and application card notifications will continue to be displayed.
Eligibility Criteria
You may qualify if:
- volunteering to participate in the study
- being literate
- being overweight
- being over the age of 18
You may not qualify if:
- Being diagnosed with substance and/or alcohol use disorder
- being illiterate
- Being pregnant or having a pregnancy plan during the research period
- Being diagnosed with a disease that causes neuroendocrine obesity (Cushing's disease, hypothyroidism, hypothalamic obesity, growth hormone deficiency, hypogonadism, pseudohypoparathyroidism, polycystic ovary syndrome)
- Using antipsychotics, antiobesity drugs or cortisone-containing drugs
- Being a cigarette-smoker
- If the participant withdraws his/her consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Eskisehir Osmangazi University Faculty of Medicine
Eskişehir, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assoc. Prof. of Psychiatry
Study Record Dates
First Submitted
March 6, 2024
First Posted
April 11, 2024
Study Start
July 15, 2022
Primary Completion
July 15, 2024
Study Completion
September 15, 2024
Last Updated
April 16, 2025
Record last verified: 2024-04